Pulse Biosciences, Inc. (Nasdaq: PLSE), pioneer of the novel nPulse™ platform using proprietary Nanosecond Pulsed Field Ablation (nsPFA™), today announced a new strategic alignment to prioritize and ...

Pulse Biosciences (Nasdaq:PLSE) announced a new strategic alignment to focus on its nPulse cardiac catheter ablation system.

The heart is an intricate plumbing system of valves, pumps and pipelike vessels which control the flow of blood throughout the body, and the doctors who specialize in its function, diagnosis and ...

BioCardia ®, Inc. [NASDAQ: BCDA] , a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced the FDA has accepted its ...

Add Yahoo as a preferred source to see more of our stories on Google. “Time is heart, and time is brain,” said President and Chief Administrative Officer of Cumberland Medical Center Randy Davis. In ...

No restriction of oral food intake prior to nonemergent cardiac catheterization is as safe as the current traditional NPO [nothing by mouth] strategy, results from a large, single-center, randomized ...

Cardiac Catheterization Care As pediatric cardiac catheterization procedures become more advanced, the need to anticipate which children will require intensive care ...

Mercy Hospital Washington in Washington, Mo., has opened an expanded cardiovascular catheterization lab as part of a $10 million project first announced in January 2024. The expansion added a third ...

Allegheny Health Network has opened its newly renovated, second cardiac catheterization lab at AHN Forbes Hospital in Monroeville. The renovation expands the hospital’s ability to deliver advanced, ...